Nevertheless, clinical correlates and biological factors involved in the modulation of the variability of serum TRAIL concentrations, particularly in subjects free of cardiovascular disease or acute inflammatory conditions, have not been elucidated so far. This evidence concerns the gene TNFSF10 and cardiovascular disorder.